| David Jeffrey Moller, MD | |
|
2025 Morse Ave, Sacramento, CA 95825-2115 | |
| (916) 973-5000 | |
| Not Available |
| Full Name | David Jeffrey Moller |
|---|---|
| Gender | Male |
| Speciality | Neurosurgery |
| Experience | 22 Years |
| Location | 2025 Morse Ave, Sacramento, California |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1356597025 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207T00000X | Neurological Surgery | 036.121196 (Illinois) | Secondary |
| 207T00000X | Neurological Surgery | A109218 (California) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Kaiser Foundation Hospital - Sacramento | Sacramento, CA | Hospital |
| Kaiser Foundation Hosp So Sacramento | Sacramento, CA | Hospital |
| Kaiser Foundation Hospital - Vacaville | Vacaville, CA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Permanente Medical Group Inc | 8921910225 | 7800 |
News Archive
Children whose bones are "older" than their chronological age may be at an increased risk of hypertension, according to a study reported today (19 October) in Hypertension: Journal of the American Heart Association.
Living kidney donors show no increase in their risk of heart attacks or other cardiovascular events in the years after donation, according to the largest-ever study of the issue, being presented at the American Society of Nephrology's 40th Annual Meeting and Scientific Exposition in San Francisco.
Clinicians have been perplexed by the fact that some patients given the drug cetuximab - an immune-based therapy commonly used to treat persons diagnosed with head and neck cancer, or colon cancer - have a severe and rapid adverse reaction to the drug.
Researchers from Monash University's Institute of Pharmaceutical Sciences are paving the way for accessible and affordable cancer treatment by using powerful nanoscale tools to overcome the high costs and long lead-times associated with one of the world's newest forms of immunotherapy: CAR-T cell therapy.
› Verified 6 days ago
| Entity Name | Permanente Medical Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1073606299 PECOS PAC ID: 8921910225 Enrollment ID: O20031104000710 |
News Archive
Children whose bones are "older" than their chronological age may be at an increased risk of hypertension, according to a study reported today (19 October) in Hypertension: Journal of the American Heart Association.
Living kidney donors show no increase in their risk of heart attacks or other cardiovascular events in the years after donation, according to the largest-ever study of the issue, being presented at the American Society of Nephrology's 40th Annual Meeting and Scientific Exposition in San Francisco.
Clinicians have been perplexed by the fact that some patients given the drug cetuximab - an immune-based therapy commonly used to treat persons diagnosed with head and neck cancer, or colon cancer - have a severe and rapid adverse reaction to the drug.
Researchers from Monash University's Institute of Pharmaceutical Sciences are paving the way for accessible and affordable cancer treatment by using powerful nanoscale tools to overcome the high costs and long lead-times associated with one of the world's newest forms of immunotherapy: CAR-T cell therapy.
› Verified 6 days ago
| Entity Name | Regents Of The Univ Of Ca |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1013906973 PECOS PAC ID: 3375456619 Enrollment ID: O20031111000892 |
News Archive
Children whose bones are "older" than their chronological age may be at an increased risk of hypertension, according to a study reported today (19 October) in Hypertension: Journal of the American Heart Association.
Living kidney donors show no increase in their risk of heart attacks or other cardiovascular events in the years after donation, according to the largest-ever study of the issue, being presented at the American Society of Nephrology's 40th Annual Meeting and Scientific Exposition in San Francisco.
Clinicians have been perplexed by the fact that some patients given the drug cetuximab - an immune-based therapy commonly used to treat persons diagnosed with head and neck cancer, or colon cancer - have a severe and rapid adverse reaction to the drug.
Researchers from Monash University's Institute of Pharmaceutical Sciences are paving the way for accessible and affordable cancer treatment by using powerful nanoscale tools to overcome the high costs and long lead-times associated with one of the world's newest forms of immunotherapy: CAR-T cell therapy.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| David Jeffrey Moller, MD 676 N Saint Clair St Ste 2210, Chicago, IL 60611-2922 Ph: (312) 922-0898 | David Jeffrey Moller, MD 2025 Morse Ave, Sacramento, CA 95825-2115 Ph: (916) 973-5000 |
News Archive
Children whose bones are "older" than their chronological age may be at an increased risk of hypertension, according to a study reported today (19 October) in Hypertension: Journal of the American Heart Association.
Living kidney donors show no increase in their risk of heart attacks or other cardiovascular events in the years after donation, according to the largest-ever study of the issue, being presented at the American Society of Nephrology's 40th Annual Meeting and Scientific Exposition in San Francisco.
Clinicians have been perplexed by the fact that some patients given the drug cetuximab - an immune-based therapy commonly used to treat persons diagnosed with head and neck cancer, or colon cancer - have a severe and rapid adverse reaction to the drug.
Researchers from Monash University's Institute of Pharmaceutical Sciences are paving the way for accessible and affordable cancer treatment by using powerful nanoscale tools to overcome the high costs and long lead-times associated with one of the world's newest forms of immunotherapy: CAR-T cell therapy.
› Verified 6 days ago
Dr. Anne H. Sholes, MD Neurological Surgery Medicare: Medicare Enrolled Practice Location: 2801 K St Ste 410, Neurosurgery, Sacramento, CA 95816 Phone: 916-733-8277 | |
Huy The Duong, M.D. Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 4860 Y St, Department Of Neurological Surgery Suite #3740, Sacramento, CA 95817 Phone: 916-734-3071 Fax: 916-452-2580 | |
Dr. Yi-ren Chen, MD, MPH Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 3939 J St Ste 250, Sacramento, CA 95819 Phone: 916-733-3401 Fax: 916-733-3410 | |
Martin Melicharek Iii, MD Neurological Surgery Medicare: Not Enrolled in Medicare Practice Location: 2025 Morse Ave, Sacramento, CA 95825 Phone: 916-973-5000 | |
Dr. Justin Dominic Paquette, M.D., M.A. Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 3800 J St Ste 210, Sacramento, CA 95816 Phone: 916-341-0310 Fax: 916-341-0340 | |
Dr. Dinesh Ramanathan, MD Neurological Surgery Medicare: Medicare Enrolled Practice Location: 4860 Y St, Suite 3740, Sacramento, CA 95817 Phone: 916-734-4300 | |
Dr. Marike Zwienenberg, M.D. Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 4860 Y St, Suite 3740, Sacramento, CA 95817 Phone: 916-734-3658 |